The nation of Zimbabwe has declined a major US healthcare agreement valued at $367m (272 million pounds) over five years because of Washington's insistence on sensitive information.
This move was revealed following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official representative later stated that the US was seeking genetic material for research and profit while refused to share the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for more negotiations to reach a deal agreeable to both sides so the country's critical HIV programme can proceed.
Broader Context
This rejection follows a similar situation in neighbouring Kenya, where a court halted a related deal with the US after legal challenges were filed about the safety of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and responsibility.
Based on statements, 16 nations in Africa have to date signed these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Effectively, our country would provide the basic resources for medical research with no certainty that the final treatments would be available to our people if a new disease outbreak arise."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks previously set up through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how subsequent collaboration could be designed in a manner that respects the independence and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations should continue since much of the nation's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," it commented.
This impasse emphasises the complex challenges between receiving much-needed foreign assistance and protecting local interests in an increasingly interconnected world.